促进儿科肿瘤药物开发
Our speakers will discuss the pediatric oncology regulatory landscape and how modeling and simulation is used in pediatric oncology drug development.
Tag: PK/PD Modeling and Simulation
Trial Simulator for NONMEM Modelers
Examples Guide Version 1 Applies to: Trial Simulator 2.3, NONMEM 7.3 As a courtesy to Certara’s Trial Simulator users, we have created this guide with 23 hypothetical examples where NONMEM codes and the corresponding TS codes are provided so that users may use these examples as templates to enter their models into Trial Simulator for … Continued
Accelerating Vaccine Development: Applications to COVID-19 and Future Pandemics
Certara 推出用于药物开发的 Phoenix™ 生物模拟软件 8.3 版
Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.—2020 年 6 月 24 日. Certara®, the global leader in biosimulation, today announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. Version 8.3 delivers new features to drive efficiencies and … Continued
Phoenix™ PK/PD 平台
Phoenix WinNonlin
Certara Integral 数据存储库
加快 COVID-19 的治疗进程
This webinar will explain lessons learned from preparing for and responding to viral outbreaks such as H5N1 and pH1N1 influenza and discuss how insights from model-informed drug development approaches can spur access to medicines for patients.
